Half Year 2026 Somnomed Ltd Earnings Call Transcript
Key Points
- SomnoMed Ltd (SOMNF) reported a record half-year revenue of $60.7 million, marking a 13% increase from the previous year.
- EBITDA increased by 35% year-on-year to $7.8 million, demonstrating improved operating leverage.
- The company closed the half with a strong cash balance of $18 million, providing financial flexibility for future investments.
- Manufacturing capacity increased by more than 20%, improving turnaround times and operational efficiency.
- The company achieved NPAT profitability in the half, marking a significant milestone in earnings progression.
- Free cash flow was negative $0.9 million, primarily due to planned capital expenditures in manufacturing and R&D.
- APAC region revenue decreased by 4%, impacted by increased competition and broader economic headwinds.
- Gross margins remained stable but slightly decreased from 61.6% to 61.3%, indicating pressure on product economics.
- The company is still awaiting a response from US customs regarding tariff exemptions under the Nairobi protocol.
- The commercialization of the Rest Assure device is still in progress, with full market execution expected in FY '27.
Good morning everybody and welcome to Songa's presentation for the first half of FY '26. With me today are Karen Borg and Amrita Blickstead, co-CEOs of Somnomed; and Ye-Fei Guo, CFO at at Somnomed, who will take you through the results presentation which was lodged with the ASX this morning.
Just a bit of housekeeping before we kick off, today's webinar is being recorded, including the Q&A, and we will post this on Somnomed's website following the completion of the webinar. We invite research analysts to ask questions at the end of the presentation, and you can either do so via the online Q&A function or raise your hand and we will take you off mute so you can ask your question that way.
And with that, I will now hand it over to Karen.
Thank you. Let's begin with our first half results. The first half of FY '26 represents a period of disciplined execution and continued growth across our core markets. We delivered a record half year revenue of $60.7 million
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
